ACTA1 and systemic sclerosis: In fibroblasts isolated form SSc patients, adenosine A2A receptors were found to be overexpressed, and the A2A receptor antagonist ZM-241385 (1 μM; 24 h) could suppress pathologically elevated α-SMA expression of these cells [75].